Clinical trials recruiting for Unresectable Triple-Negative Breast Carcinoma
5
Recruiting trials
7
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 4Phase 2 2
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 2 |
| Massachusetts | 2 |
| New York | 2 |
| Florida | 1 |
| Missouri | 1 |
| Ohio | 1 |
| Tennessee | 1 |
Top cities
Atlanta, Georgia 2Boston, Massachusetts 2Buffalo, New York 1Columbus, Ohio 1Jacksonville, Florida 1Mineola, New York 1Nashville, Tennessee 1New York, New York 1St Louis, Missouri 1
Self-screener
Recruiting trials
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
- Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
- Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
- Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Related conditions
Trials recruiting for Unresectable Triple-Negative Breast Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Metastatic Triple-Negative Breast Carcinoma 18Breast cancer 2239Anatomic Stage IV Breast Cancer AJCC v8 43Anatomic Stage III Breast Cancer AJCC v8 39Locally Advanced Triple-Negative Breast Carcinoma 4Unresectable Malignant Solid Neoplasm 8Metastatic Malignant Solid Neoplasm 21Anatomic Stage IIIC Breast Cancer AJCC v8 7Anatomic Stage IIIB Breast Cancer AJCC v8 7Anatomic Stage IIIA Breast Cancer AJCC v8 10
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Unresectable Triple-Negative Breast Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.